Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.

ArticleAçık Erişim
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/20346Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5501/wjv.v12.i2.132Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGulmez, AO
dc.contributor.authorAydin, S
dc.date.accessioned2026-10-18T21:14:16.683161441Z
dc.date.available2026-10-18T21:14:16.683161441Z
dc.date.issued2023
dc.identifier.doi10.5501/wjv.v12.i2.132
dc.identifier.endpage135
dc.identifier.issue2
dc.identifier.pmcidPMC10075052
dc.identifier.pmid37033145
dc.identifier.startpage132
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/20346
dc.identifier.volume12
dc.language.isoen
dc.relation.ispartofWorld journal of virology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleUtility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
dc.typeArticle
dspace.entity.typePublication
rdl.departmentDepartment of Radiology, Erzincan University, Erzincan 24100, Turkey. aliosmangulmez.2@gmail.com. | Department of Radiology, Erzincan University, Erzincan 24100, Turkey.
rdl.source.indexPUBMED